Jeffrey L. Wade
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey L. Wade
Jeffrey L. Wade is recorded as COO at Lexicon Pharmaceuticals, Inc. (LXRX). Lexicon Pharmaceuticals, Inc. reported in an 8-K filed July 8, 2024 that Jeffrey L. Wade was appointed president and chief operating officer, effective July 8, 2024. The proxy statement of Lexicon Pharmaceuticals, Inc. reports total compensation of $2,564,274 for Jeffrey L. Wade in fiscal 2024, including a base salary of $485,525. Disclosed compensation is on record for 8 fiscal years.
“Also effective as of July 8, 2024, Jeffrey L. Wade was promoted from our president and chief financial officer to our president and chief operating officer, in which capacity Mr. Wade will report to Dr. Exton and perform the functions of our president, principal operating officer and principal financial officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-08–present
-
Current
2021-10-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexicon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Exton, Ph.D. CEO, Board Member
- Michael S. Exton CEO, Board Member
- Raymond Debbane Chairman
- Kristen L. Alexander CFO, Chief Accounting Officer
- Christopher J. Sobecki Board Member
- Diane E. Sullivan Board Member
- Ivan H. Cheung Board Member
- Judith L. Swain Board Member
- Philippe J. Amouyal Board Member
- Samuel L. Barker Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $485,525 | $2,564,274 |
| 2023 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $535,729 | $1,962,868 |
| 2022 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $513,354 | $1,990,163 |
| 2021 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $476,319 | $1,651,683 |
| 2020 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $456,372 | $1,629,502 |
| 2019 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $444,431 | $1,614,323 |
| 2018 | Lexicon Pharmaceuticals, Inc. (LXRX) | Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer | $436,644 | $1,408,003 |
| 2017 | Lexicon Pharmaceuticals, Inc. (LXRX) | Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer | $427,038 | $1,214,435 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.